Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis
Clinical trial NCT04170426 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04170426
- Sponsor
- Celltex Therapeutics Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-12-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.